HHV8 A Subtype Is Associated With Rapidly Evolving Classic Kaposi's SarcomaMANCUSO, Roberta; BIFFI, Renato; CLERICI, Mario et al.Journal of medical virology. 2008, Vol 80, Num 12, pp 2153-2160, issn 0146-6615, 8 p.Article

Classic Kaposi's sarcoma in Italy, 1985-1998DAL MASO, L; POLESEL, J; VERCELLI, M et al.British journal of cancer. 2005, Vol 92, Num 1, pp 188-193, issn 0007-0920, 6 p.Article

Classic Kaposi's sarcoma in southern Sardinia, ItalyATZORI, L; FADDA, D; FERRELI, C et al.British journal of cancer. 2004, Vol 91, Num 7, pp 1261-1262, issn 0007-0920, 2 p.Article

Staging of classic Kaposi's sarcoma: a useful tool for therapeutic choicesBRAMBILLA, Lucia; BONESCHI, Vinicio; TAGLIONI, Michela et al.EJD. European journal of dermatology. 2003, Vol 13, Num 1, pp 83-86, issn 1167-1122, 4 p.Article

Epidemiology of classic Kaposi's sarcoma in the Israeli Jewish population between 1960 and 1998GUTTMAN-YASSKY, E; BAR-CHANA, M; YUKELSON, A et al.British journal of cancer. 2003, Vol 89, Num 9, pp 1657-1660, issn 0007-0920, 4 p.Article

Epidemiology and clinical characteristics of classic Kaposi's sarcoma, seroprevalence, and variants of human herpesvirus 8 in South America : A critical review of an old diseaseMOHANNA, Salim; MACO, Vicente; BRAVO, Francisco et al.International journal of infectious diseases. 2005, Vol 9, Num 5, pp 239-250, issn 1201-9712, 12 p.Article

Weekly paclitaxel for advanced aggressive classic Kaposi sarcoma : experience in 17 casesBRAMBILLA, L; ROMANELLI, A; BELLINVIA, M et al.British journal of dermatology (1951). 2008, Vol 158, Num 6, pp 1339-1344, issn 0007-0963, 6 p.Article

Human herpesvirus type 8 infection in an area of Northern Italy with high incidence of classical Kaposi's sarcomaTANZI, Elisabetta; ZAPPA, Alessandra; CARAMASCHI, Fausta et al.Journal of medical virology. 2005, Vol 76, Num 4, pp 571-575, issn 0146-6615, 5 p.Article

Intralesional vincristine as first-line therapy for nodular lesions in classic Kaposi sarcoma: a prospective study in 151 patientsBRAMBILLA, L; BELLINVIA, M; TOURLAKI, A et al.British journal of dermatology (1951). 2010, Vol 162, Num 4, pp 854-859, issn 0007-0963, 6 p.Article

Classical Kaposi sarcoma: Prognostic factor analysis of 248 patientsBRENNER, Baruch; WEISSMANN-BRENNER, Alina; RAKOWSKY, Erica et al.Cancer. 2002, Vol 95, Num 9, pp 1982-1987, issn 0008-543X, 6 p.Article

Disseminated classic Kaposi's sarcoma. Two cases with excellent response to pegylated liposomal doxorubicinCASTINEIRAS, Iria; ALMAGRO, Manuel; RODRIGUEZ-LOZANO, Jesus et al.Journal of dermatological treatment. 2006, Vol 17, Num 6, pp 377-380, issn 0954-6634, 4 p.Article

Classic Kaposi sarcoma : Which KSHV-seropositive individuals are at risk?GUTTMAN-YASSKY, Emma; DUBNOV, Jonathan; KRA-OZ, Zippi et al.Cancer. 2006, Vol 106, Num 2, pp 413-419, issn 0008-543X, 7 p.Article

Relationship between human herpesvirus 8 loads and disease stage in classic Kaposi sarcoma patientsGUTTMAN-YASSKY, Emma; ABADA, Rinat; KRA-OZ, Zipi et al.Diagnostic microbiology and infectious disease. 2007, Vol 57, Num 4, pp 387-392, issn 0732-8893, 6 p.Article

Update on classic Kaposi sarcoma therapy : New look at an old diseaseDI LORENZO, Giuseppe.Critical reviews in oncology/hematology. 2008, Vol 68, Num 3, pp 242-249, issn 1040-8428, 8 p.Article

Pegylated Liposomal Doxorubicin as Second-line Therapy in the Treatment of Patients With Advanced Classic Kaposi Sarcoma : A Retrospective StudyDI LORENZO, Giuseppe; DI TROLIO, Rossella; MONTESARCHIO, Vincenzo et al.Cancer. 2008, Vol 112, Num 5, pp 1147-1152, issn 0008-543X, 6 p.Article